Search Results 121-130 of 20732 for ulcerative colitis

  1. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview ... Ulcerative Colitis (UC). Participation eligibility. Participant eligibility ...

  2. Crohn's disease - Doctors and departments - Mayo Clinic

    A Book: Mayo Clinic on Crohn's Disease and Ulcerative Colitis · A Book: Mayo Clinic on Digestive Health · Nutritional Supplements at Mayo Clinic Store. Show ...

  3. Budesonide (oral route) - Mayo Clinic

    Budesonide is a steroid (cortisone-like) medicine. Budesonide extended-release tablets are used to help get active mild to moderate ulcerative colitis under ...

  4. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo Clinic Footer.

  5. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001).

  6. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

    A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... Ulcerative Colitis (UC) or Crohn's disease ...

  7. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

  8. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...

  9. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.

  10. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.